Psychiatry & Neurology, Neuromuscular Medicine · New York, NY
NPI
1215224266
Since 2011
Specialty
Psychiatry & Neurology, Neuromuscular Medicine
Code 2084N0008X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
710 W 168th St # Ni-3
New York, NY, 10032
Phone (212) 305-6788
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
651 services
Medicare patients, 2024
137
Average age 72
Drug cost, 2024
$2.2M
609 prescriptions
Company payments, 2025
$14K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ikjae Lee was code 95886 (electrical nerve conductivity), 93 times for 70 patients. In total Ikjae Lee billed 651 services in 26 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Office | 93 | 70 | $100.10 | $9,310 |
| 99215 Office E&M - Established | Office | 89 | 45 | $155.29 | $14K |
| 94010 Pulmonary Function Testing | Office | 60 | 32 | $24.10 | $1,446 |
| 92610 Speech Therapy | Office | 52 | 30 | $73.26 | $3,810 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 48 | 36 | $14.95 | $717 |
| 92522 Speech Therapy | Office | 43 | 26 | $86.45 | $3,717 |
| 95911 Electrical Nerve Conductivity | Office | 35 | 35 | $186.94 | $6,543 |
| 95885 Electrical Nerve Conductivity | Office | 33 | 28 | $59.37 | $1,959 |
| 94681 Pulmonary Function Testing | Office | 30 | 24 | $44.94 | $1,348 |
| 97162 PT/OT Evaluation | Office | 28 | 20 | $84.37 | $2,362 |
| 99205 Office E&M - New | Office | 20 | 20 | $184.81 | $3,696 |
| 99214 Office E&M - Established | Office | 20 | 14 | $107.28 | $2,146 |
| 97163 PT/OT Evaluation | Office | 18 | 17 | $89.37 | $1,609 |
| 97161 PT/OT Evaluation | Office | 15 | 13 | $94.58 | $1,419 |
| 95913 Electrical Nerve Conductivity | Office | 13 | 13 | $273.19 | $3,551 |
By year: 2022 $62K for 586 services; 2023 $57K for 551 services; 2024 $63K for 651 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 22 | 18 | $2.84 | $62.43 |
Medicare prescription drug claims, 2024
In 2024, the drug Ikjae Lee prescribed most often to Medicare patients was Riluzole, with 150 prescriptions and refills. In total Ikjae Lee wrote 609 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Riluzole Generic | 150 | 235 | 31 | $12K |
| Radicava Ors Edaravone | 62 | 62 | Under 11 | $831K |
| Atropine Sulfate Generic | 44 | 49 | 12 | $1,488 |
| Gabapentin Generic | 43 | 57 | Under 11 | $785 |
| Relyvrio Sod Phenylbutyrat/Taurursodiol | 42 | 42 | 16 | $514K |
| Trazodone Hcl Generic | 24 | 48 | Under 11 | $111 |
| Baclofen Generic | 23 | 31 | Under 11 | $753 |
| Mirtazapine Generic | 18 | 40 | Under 11 | $624 |
| Mestinon Pyridostigmine Bromide | 18 | 25 | Under 11 | $56K |
| Sertraline Hcl Generic | 16 | 21 | Under 11 | $201 |
| Amitriptyline Hcl Generic | 14 | 28 | Under 11 | $164 |
| Pyridostigmine Bromide Generic | 13 | 26 | Under 11 | $1,067 |
| Nuedexta Dextromethorphan Hbr/Quinidine | 12 | 12 | Under 11 | $20K |
| Prednisone Generic | 12 | 12 | Under 11 | $38.46 |
| Diclofenac Sodium Generic | 11 | 11 | Under 11 | $320 |
Brand drugs: - claims; generic drugs: 435 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ikjae Lee $14K ($11K in general payments such as food, travel and fees and $3,213 for research) from 2 companies. The largest payer was Argenx US, Inc. with $11K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.